Stay updated on Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and the v3.4.1 notice was removed. This appears to be a site maintenance update that does not affect the clinical trial details on the page.SummaryDifference0.5%

- Check21 days agoChange DetectedSite-wide notices were added about government funding lapse and clinic operations, and the site revision was updated to v3.4.1 (removing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedShow glossary option added and metadata labels updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3, indicating a version update of the page. No study details or user-facing functionality are altered.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 is now displayed; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision history updated to add v3.3.2 and remove v3.3.1. These are administrative metadata changes that do not modify study content.SummaryDifference0.1%

Stay in the know with updates to Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.